The intent of the Clinical Trial Development Award is to provide support to establish the necessary collaborations and develop the necessary research resources that will serve as a foundation for investigator-initiated clinical trials. The goal of these awards is the development of Phase I or Phase II clinical trial(s) that will have a major impact on the treatment, diagnosis, detection, or prevention of prostate cancer. As such, they should focus on new interventions and not on the refinements of existing interventions (e.g., optimizing timing or dosage regimens). Funds for Clinical Trial Development Awards will be disbursed in two installments, both of which can cover administrative support directly associated with planning, development, and review of the clinical trial or the clinical protocol and consent form. Funds may not be used to support laboratory or preclinical research.
Who can apply:
Eligible functional categories:
Military Medical Research and Development
Department of Defense (DOD) Fiscal Year 2005 (FY05) Prostate Cancer Research Program (PCRP) Clinical Trial Development Award (CTDA)
If you have problems accessing the full announcement, please contact:
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014